Results 11 to 20 of about 4,080 (215)
Journal of Dental Sciences, 2021 Background/purpose: Because the anatomy and the nature of the bone tissue between the mandible and maxilla are largely different, more site-specific studies are required to improve the healing rate on medication-related osteonecrosis of the jaw (MRONJ ...
Kohei Okuyama +8 more
doaj +2 more sources
Adjuvant therapies for MRONJ: A systematic review
Bone, 2020 Medication-related osteonecrosis of the jaw (MRONJ) is a severe adverse reaction caused by the use of antiresorptive antiangiogenic medication. Treating MRONJ is difficult and besides standard treatments, which are conservative medical and surgical approaches, there are some adjuvant therapies that might further stimulate healing.
Govaerts, Dries +5 more
openaire +3 more sources
Challenges and Controversies in the Diagnosis of MRONJ [PDF]
The XV National and III International Congress of the Italian Society of Oral Pathology and Medicine, 2019 Medication-related osteonecrosis of the jaw (MRONJ) is a relatively rare but potentially seriousand debilitating complication [...]
Fede, Olga Di, Campisi, Giuseppina
openaire +4 more sources
Journal of Craniomaxillofacial Research, 2021 Background: Medication related osteonecrosis of the jaw (MRONJ) is a chronic condition of the oral cavity resulting in mucosal ulceration and exposure of underlying necrotic bone, and the ensuing secondary complications.
Gholamreza Shirani +5 more
doaj +2 more sources
Clinical and Histopathological Aspects of MRONJ in Cancer Patients
Journal of Clinical Medicine, 2023 Medication-related osteonecrosis of the jaw (MRONJ) is a major complication of bisphosphonate treatment in cancer patients, and its etiology is not completely clarified. The study’s goal is to find connections between the clinical and histopathological characteristics of osteonecrosis and bisphosphonates in a cohort of cancer patients who had ...
George Adrian Ciobanu +10 more
openaire +3 more sources
BMC Oral HealthBackground Medication-Related Osteonecrosis of the Jaw (MRONJ), an established side effect of antiresorptive and antiangiogenic medication, could sometimes require surgical intervention, such as decortication. The objectives of this retrospective patient
Oliver Bissinger +6 more
doaj +2 more sources
Fractal dimension in CBCT images as predictor for MRONJ: a retrospective cohort study. [PDF]
, 2021 OBJECTIVE To estimate boxcounting fractal dimension in a standardized approach in CBCT images of the mandible and maxilla in a group of patients with MRONJ in comparison to a healthy control group.
Schulze, Ralf K. W. +2 more
core +2 more sources
Saudi Pharmaceutical Journal, 2023 Osteoporosis is the most common indication for antiresorptive drugs (ARDs). Medication-related osteonecrosis of the jaw (MRONJ) is a severe complication of ARDs.
Suad Aljohani
doaj +1 more source
Scientific Reports, 2021 Tooth extraction has been avoided since it has been considered a major risk factor for medication-related osteonecrosis of the jaw (MRONJ). However, MRONJ may also develop from tooth that is an infection source.
Sakiko Soutome +10 more
doaj +1 more source
International Journal of Implant Dentistry, 2021 Background Medication-related osteonecrosis of the jaw (MRONJ), which was first reported as bisphosphonate-related osteonecrosis of the jaw (BRONJ) in bisphosphonate users, is a rare but severe soft and hard tissue disease induced by several types of ...
Mampei Kawahara +2 more
doaj +1 more source